00000nam 2200000za 4500 9.864450 CaOODSP 20221107161538 cr ||||||||||| 181108s1981 onc #ot f|0| 0 eng d CaOODSP eng eng fre n-cn--- EC24-11/8-1981E-PDF Gorecki, Paul K., 1948- Regulating the price of prescription drugs in Canada [electronic resource] : compulsory licensing, product selection, and government reimbursement programmes / by Paul K. Gorecki. Ottawa : Economic Council of Canada, 1981. xiii, 300 p. : figures, charts. Technical report - Economic Council of Canada, 0225-8013 ; no. 8 "May 1981." Digitized edition from print [produced by the Publishing and Depository Services Directorate]. Includes bibliographic references. "The major findings of the study can be summarized as follows: prices have fallen, often substantially, at the level of the manufacturer for those drugs subject to licensee competition. These price reductions have been passed on to the consumer in the hospital market and, in varying degrees, in the provincial retail drug markets. It is not uncommon for expenditure on a particular licensed drug to be reduced by 50 percent from what it would have been without compulsory licensing and associated policy measures. Nevertheless further gains, often of considerable magnitude, can be achieved in virtually all markets"--Summary, p. xii. Includes abstract in French. gccst Prescription drugs gccst Price regulation Economic Council of Canada. Technical report (Economic Council of Canada) 0225-8013 ; no. 8. (CaOODSP)9.855538 PDF 32.98 MB https://publications.gc.ca/collections/collection_2018/ecc/EC24-11-8-1981-eng.pdf